Real-time US stock institutional ownership tracking and fund flow analysis to understand who owns and is buying the stock. We monitor 13F filings and institutional buying patterns because large investors often have superior information.
Celldex Therapeutics Inc. (CLDX) is trading at $31.35 as of 2026-04-07, posting a modest 0.06% dip in today’s session amid flat broader market trading for healthcare stocks. This analysis outlines key technical levels, prevailing market context, and potential short-term price scenarios for the clinical-stage biotech stock, with no recent earnings data available for the company as of publication. There are no confirmed, publicly disclosed pipeline or regulatory events scheduled for the near term
What are analysts saying about Celldex (CLDX) Stock | Price at $31.35, Down 0.06% - AI Powered Stock Picks
CLDX - Stock Analysis
4584 Comments
1068 Likes
1
Fredith
Registered User
2 hours ago
Market participants are cautiously optimistic, awaiting further economic or corporate developments.
👍 221
Reply
2
Collin
Engaged Reader
5 hours ago
Discover high-potential US stocks with expert guidance, real-time updates, and proven strategies focused on long-term growth and controlled risk exposure. Our comprehensive approach ensures you have all the information needed to make smart investment choices in today's fast-paced market.
👍 288
Reply
3
Smithy
Engaged Reader
1 day ago
Indices are in a consolidation phase — potential for breakout exists.
👍 171
Reply
4
Cynitha
Active Reader
1 day ago
Free US stock comparative valuation tools and peer analysis to identify mispriced securities in the market. We help you understand relative value across different metrics and time periods to find the best opportunities.
👍 47
Reply
5
Kisan
Loyal User
2 days ago
This feels like something I’ll regret later.
👍 42
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.